• 1
    Eckersall PD, Bell R. Acute phase proteins: Biomarkers of infection and inflammation in veterinary medicine. Vet J 2010;185:2327.
  • 2
    Petersen HH, Nielsen JP, Heegaard PM. Application of acute phase protein measurements in veterinary clinical chemistry. Vet Res 2004;35:163187.
  • 3
    Ceron JJ, Eckersall PD, Martynez-Subiela S. Acute phase proteins in dogs and cats: Current knowledge and future perspectives. Vet Clin Pathol 2005;34:8599.
  • 4
    Conner JG, Eckersall PD, Ferguson J, Douglas TA. Acute phase response in the dog following surgical trauma. Res Vet Sci 1988;45:107110.
  • 5
    Kocaturk M, Martinez S, Eralp O, et al. Prognostic value of serum acute-phase proteins in dogs with parvoviral enteritis. J Small Anim Pract 2010;51:478483.
  • 6
    Martinez-Subiela S, Tecles F, Eckersall PD, Ceron JJ. Serum concentrations of acute phase proteins in dogs with leishmaniasis. Vet Rec 2002;150:241244.
  • 7
    Shimada T, Ishida Y, Shimizu M, et al. Monitoring C-reactive protein in Beagle dogs experimentally inoculated with Ehrlichia canis. Vet Res Commun 2002;26:171177.
  • 8
    Jergens AE, Schreiner CA, Frank DE, et al. A scoring index for disease activity in canine inflammatory bowel disease. J Vet Intern Med 2003;17:291297.
  • 9
    Bathen-Noethen A, Carlson R, Menzel D, et al. Concentrations of acute-phase proteins in dogs with steroid responsive meningitis-arteritis. J Vet Intern Med 2008;22:11491156.
  • 10
    Mitchell KD, Kruth SA, Wood RD, Jefferson B. Serum acute phase protein concentrations in dogs with autoimmune hemolytic anemia. J Vet Intern Med 2009;23:585591.
  • 11
    Ohno K, Yokoyama Y, Nakashima K, et al. C-reactive protein concentration in canine idiopathic polyarthritis. J Vet Med Sci 2006;68:12751279.
  • 12
    Nielsen L, Toft N, Eckersall PD, et al. Serum C-reactive protein concentration as an indicator of remission status in dogs with multicentric lymphoma. J Vet Intern Med 2007;21:12311236.
  • 13
    Planellas M, Bassols A, Siracusa C, et al. Evaluation of serum haptoglobin and C-reactive protein in dogs with mammary tumors. Vet Clin Pathol 2009;38:348352.
  • 14
    Fransson BA, Karlstam E, Bergstrom A, et al. C-reactive protein in the differentiation of pyometra from cystic endometrial hyperplasia/mucometra in dogs. J Am Anim Hosp Assoc 2004;40:391399.
  • 15
    Dabrowski R, Kostro K, Lisiecka U, et al. Usefulness of C-reactive protein, serum amyloid a component, and haptoglobin determinations in bitches with pyometra for monitoring early post-ovariohysterectomy complications. Theriogenology 2009;72:471476.
  • 16
    Yamamoto S, Shida T, Okimura T, et al. Determination of C-reactive protein in serum and plasma from healthy dogs and dogs with pneumonia by ELISA and slide reversed passive latex agglutination test. Vet Q 1994;16:7477.
  • 17
    Nakamura M, Takahashi M, Ohno K, et al. C-reactive protein concentration in dogs with various diseases. J Vet Med Sci 2008;70:127131.
  • 18
    Yamamoto S, Shida T, Honda M, et al. Serum C-reactive protein and immune responses in dogs inoculated with Bordetella bronchiseptica (phase I cells). Vet Res Commun 1994;18:347357.
  • 19
    Rush JE, Lee ND, Freeman LM, Brewer B. C-reactive protein concentration in dogs with chronic valvular disease. J Vet Intern Med 2006;20:635639.
  • 20
    Cunningham SM, Rush JE, Freeman LM. Systemic inflammation and endothelial dysfunction in dogs with congestive heart failure. J Vet Intern Med 2012;26:547557.19.
  • 21
    Lippi G, Meschi T, Cervellin G. Inflammatory biomarkers for the diagnosis, monitoring and follow-up of community-acquired pneumonia: clinical evidence and perspectives. Eur J Intern Med 2011;22:460465.
  • 22
    Bafadhel M, Clark TW, Reid C, et al. Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD. Chest 2011;139:14101418.
  • 23
    Blasi FF, Stolz DF, Piffer F. Biomarkers in lower respiratory tract infections. Pulm Pharmacol Ther 2010;23(6):501507.
  • 24
    Rajamaki MM, Jarvinen AK, Sorsa T, Maisi P. Clinical findings, bronchoalveolar lavage fluid cytology and matrix metalloproteinase-2 and -9 in canine pulmonary eosinophilia. Vet J 2002;163:168181.
  • 25
    Nilsson TK, Boman K, Jansson JH, et al. Comparison of soluble thrombomodulin, von Willebrand factor, tPA/PAI-1 complex, and high-sensitivity CRP concentrations in serum, EDTA plasma, citrated plasma, and acidified citrated plasma (Stabilyte) stored at -70 degrees C for 8–11 years. Thromb Res 2005;116:249254.
  • 26
    Melamies MA, Jarvinen AK, Seppala KM, et al. Comparison of results for weight-adjusted and fixed-amount bronchoalveolar lavage techniques in healthy Beagles. Am J Vet Res 2011;72:694698.
  • 27
    Creevy KE. Airway evaluation and flexible endoscopic procedures in dogs and cats: laryngoscopy, transtracheal wash, tracheobronchoscopy, and bronchoalveolar lavage. Vet Clin North Am Small Anim Pract 2009;39:869880.
  • 28
    Wood EF, O'Brien RT, Young KM. Ultrasound-guided fine-needle aspiration of focal parenchymal lesions of the lung in dogs and cats. J Vet Intern Med 1998;12:338342.
  • 29
    Peeters DE, McKiernan BC, Weisiger RM, et al. Quantitative bacterial cultures and cytological examination of bronchoalveolar lavage specimens in dogs. J Vet Intern Med 2000;14:534541.
  • 30
    Kuehn NF. Chronic Bronchitis in Dogs. In: King LG, ed. Respiratory Disease in Dogs and Cats, 1st ed. St. Louis, MO: Saunders; 2004:379387.
  • 31
    Heikkila HP, Lappalainen AK, Day MJ, et al. Clinical, bronchoscopic, histopathologic, diagnostic imaging, and arterial oxygenation findings in West Highland White Terriers with idiopathic pulmonary fibrosis. J Vet Intern Med 2011;25:433439.
  • 32
    Kuribayashi T, Shimada T, Matsumoto M, et al. Determination of serum C-reactive protein (CRP) in healthy Beagle dogs of various ages and pregnant Beagle dogs. Exp Anim 2003;52:387390.
  • 33
    Ibraimi F, Ekberg B, Kriz D, et al. Preparation of a portable point-of-care in vitro diagnostic system, for quantification of canine C-reactive protein, based on a magnetic two-site immunoassay. Anal Bioanal Chem 2013;405:60016007.
  • 34
    Garcia LS, ed. 2007 Update: Clinical Microbiology Procedures Handbook, 2nd ed. Washington DC: ASM Press; 2007.
  • 35
    Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard, 3rd ed. CLSI document M31-A3; Wayne, PA: CLSI, 2008.
  • 36
    Conover WJ. Rank transformations as a bridge between parametric and nonparametric statistics. Am Stat 1981;35:124.
  • 37
    Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections–summary. Clin Microbiol Infect 2011;17(Suppl. 6):124.
  • 38
    Lim WS, Baudouin SV, George RC, et al. British Thoracic Society Guidelines for the management of community acquired pneumonia in adults: Update 2009. Thorax 2009;64(Suppl. 3):iii1iii55.
  • 39
    Mandel L, Wunderink R, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44:S27S72.
  • 40
    White M, Ducharme A, Ibrahim R, et al. Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: Improvement after short-term inotropic support. Clin Sci (Lond) 2006;110:483489.
  • 41
    Yin WH, Chen JW, Jen HL, et al. Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure. Am Heart J 2004;147:931938.
  • 42
    Dinarello CA. Proinflammatory cytokines. Chest 2000;118:503508.
  • 43
    Witko-Sarsat V, Rieu P, Descamps-Latscha B, et al. Neutrophils: Molecules, functions and pathophysiological aspects. Lab Invest 2000;80:617653.